| Mrs Jesiah Lou Bertsch, | |
|
2139 Auburn Ave, Cincinnati, OH 45219-2906 | |
| (513) 721-2221 | |
| (513) 345-6665 |
| Full Name | Mrs Jesiah Lou Bertsch |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 15 Years |
| Location | 2139 Auburn Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376867481 | NPI | - | NPPES |
| 3083792 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | COA.11377-NM (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Christ Hospital Medical Associates, Llc | 0244314102 | 267 |
News Archive
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be compensated by Medicare and other insurers for diabetes management.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
When dining out, 65 percent of Americans prefer to see nutritional information on a restaurant menu over calories alone. As several cities around the country adapt to menu-labeling mandates that require restaurants to post calorie-counts on their menu, it is yet to be determined if it will have the desired impact on consumer behavior and therefore overall public health.
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.
› Verified 2 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be compensated by Medicare and other insurers for diabetes management.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
When dining out, 65 percent of Americans prefer to see nutritional information on a restaurant menu over calories alone. As several cities around the country adapt to menu-labeling mandates that require restaurants to post calorie-counts on their menu, it is yet to be determined if it will have the desired impact on consumer behavior and therefore overall public health.
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.
› Verified 2 days ago
| Entity Name | The Christ Hospital Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114107919 PECOS PAC ID: 0244314102 Enrollment ID: O20080301000140 |
News Archive
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be compensated by Medicare and other insurers for diabetes management.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
When dining out, 65 percent of Americans prefer to see nutritional information on a restaurant menu over calories alone. As several cities around the country adapt to menu-labeling mandates that require restaurants to post calorie-counts on their menu, it is yet to be determined if it will have the desired impact on consumer behavior and therefore overall public health.
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jesiah Lou Bertsch, Po Box 636256, Cincinnati, OH 45263-6256 Ph: (513) 245-3600 | Mrs Jesiah Lou Bertsch, 2139 Auburn Ave, Cincinnati, OH 45219-2906 Ph: (513) 721-2221 |
News Archive
The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.
The National Community Pharmacists Association (NCPA) and the American Association of Diabetes Educators (AADE) today announced a partnership that will expand counseling options for patients while offering community pharmacies a path to be compensated by Medicare and other insurers for diabetes management.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
When dining out, 65 percent of Americans prefer to see nutritional information on a restaurant menu over calories alone. As several cities around the country adapt to menu-labeling mandates that require restaurants to post calorie-counts on their menu, it is yet to be determined if it will have the desired impact on consumer behavior and therefore overall public health.
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.
› Verified 2 days ago
Mrs. Meryll Guillory Thomas-langford, APRN.CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 | |
Leah A. Terhune, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4244 Hamilton Ave, Cincinnati, OH 45223 Phone: 513-681-4900 Fax: 513-853-8432 | |
Donna O Patno, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3333 Burnet Ave, Cincinnati, OH 45229 Phone: 513-636-9608 | |
Ms. Nancy Lynn Baron, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3440 Burnet Ave, Ste. 120, Cincinnati, OH 45229 Phone: 513-751-5900 Fax: 513-487-4590 | |
Deena Jo Parsons, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3440 Burnet Ave, Suite 120, Cincinnati, OH 45229 Phone: 513-751-5900 Fax: 513-487-4590 | |
Mrs. Andrea Chipps, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3440 Burnet Ave, Cincinnati, OH 45229 Phone: 513-751-5900 | |
Sapphira Champange Pranger, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 Fax: 513-487-4590 |